Insulin secretion and insulin sensitivity in relation to glucose tolerance in a group of subjects at a high risk for type 2 diabetes mellitus;Relación de ia sensibilidad a ia insulina y de ia secreción de insulina con el grado de tolerancia a la glucosa en un grupo de personas de riesgo para desarrollar diabetes mellitus tipo 2

Medicina Clinica

Volumn 116, Issue 13, 2001, Pages 491-492

  Conget, Ignacio ^a   Real, José Manuel Fernández ^b   Costa, Àngels ^a   Casamitjana, Roser ^a   Ricart, Wifredo ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b Hospital Clinic i Universtari ^*

Author keywords

Diabetes mellitus; Impaired fasting glucose; Insulin secretion; Insulin sensitivity; Oral glucose tolerance

Indexed keywords

INSULIN;

ADULT; ARTICLE; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; RISK FACTORS;

EID: 0035820470     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0025-7753(01)71882-9     Document Type: Article

References (10)

1. The expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of the diabetes mellitus. Diabetes Care 1997; 20: 1183-1197.
2. Alberti KGMM, Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications. I. Diagnosis and classsification of diabetes mellitus: provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
3. Costa B, Martin F, Donado A, Parera F, Piñol JL, Basora J et al. Diabetes ignorada y otras alteracones del metabolismo glucídico en la población española de alto riesgo. El estudio ITG. Med Clin (Barc) 2000; 114: 601-608.
4. A Costa, I Conget, R Treserras, R Gomis. Utilidad de la glucemia basal y de la hemoglobina glicada para la detección de tolerancia anormal a la glucosa en familiares de pacientes con diabetes mellitus tipo 2. Med Clin (Barc) 1999; 112: 241-244.
5. Saad MF, Stell GM, Kades WW, Ayad MF, Elsewafy WA, Boyadjian R et al. Differences between the tolbutamide-boosted and the insulin-modified minimal model protocols. Diabetes 1997; 46: 1167-1171.
6. Pacini G, Bergman RN. MINMOD: a computer program to calculate insulin sensitivity and pancreatic resposivity from the frequently sampled intravenous glucose tolerance test. Computer Methods Progr Biomed 1986; 23: 113-122.
7. O'Rahilly SO, Hattersley A, Vaag A, Gray H. Insulin resistance as the major cause of impaired glucose tolerance: a self-fulfilling prophesy? Lancet 1994; 344: 585-589.
8. Shaw JE, De Courten MP, Hodge AM, McCarty D. Gareeboo H, Chitson P et al. IGT or IFG for predicting NIDDM. Who is right, WHO or ADA? Diabetes 1998; 47 (Supl 1): 150.
9. Tripathy D, Carlsson, Almgren P, lsomaa B, Taskinen MR, Tuomi T et al. Insulin secretion and insulin sensitivity in relation to glucose tolerance. Diabetes 2000; 49: 975-980.
10. Vehkavaara S, Seppala A, Westerbacka J, Groop PH, Yki-Jarvinen H. In vivo endothelial dysfunction characterize patients with impaired fasting glucose. Diabetes Care 1999; 22: 2055-2060.